|
| |
BioPortfolio's Approved Drugs DatabaseAbilifyAripiprazoleDownload PDF containing detailed information.
Press Releases About Abilify:
|
 |
| Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018 |
5th November, 2009 |
Decision Resources |
WALTHAM, Mass., Nov. 5 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that widespread generic erosion
|
| Seroquel's First- and Second-Line Patient Share Has Grown Since Last Year's Analysis of Prescribing Trends in Bipolar Disorder |
22nd June, 2009 |
Decision Resources |
Although Risperidone Is Now Available In Generics, There Is No Clear Evidence of Expanded Uptake in Early Lines of Therapy, According to a New Report from Decision Resources
Patient-Flow Forecasts
|
| Lexapro Loses First-Line Position for the Treatment of Major Depression |
12th May, 2009 |
Decision Resources |
Use of Atypicals In Major Depression Treatment Is Growing, According to a New Report from Decision Resources
Patient-Flow Forecasts Between Pristiq and Effexor XR Need to Take Into Account
|
| For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms |
27th April, 2009 |
Decision Resources |
Lamictal Will Retain Decision Resources' Clinical Gold Standard Status for Bipolar Depression, According to a New Report from Decision Resources
WALTHAM, Mass., April 27 /PRNewswire/ -- Decision
|
| Modest Drug Pipeline and Significant Generic Erosion Will Decrease the Bipolar Depression Drug Market by More Than $1 Billion Through 2017 |
3rd December, 2008 |
Decision Resources |
WALTHAM, Mass., Dec. 3 /PRNewswire/ -- Decision Resources, one of the
world's leading research and advisory firms for pharmaceutical and healthcare
issues, finds that the modest introduction
|
Companies working in the area of Abilify from Bioportfolio's Biocorporate database : | |
| Company Name | |
Dr. C. Anthony Altar is President and Chief Scientific Officer at Psychiatric Genomics. His research team is responsible for gene discovery, medicinal chemistry, and drug discovery efforts. Dr. Altar...
www.psygenomics.com/ View full profile
| |
This page has been viewed 119 times
Recent Search Terms used to find this page: risperidone in conjunction with abilify | current abilify research | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Abilify across BioPortfolio, or for Abilify Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
